Electrophysiological effects of the multimodal antidepressant LU AA21004 on serotonin transmission in the rat hippocampus

被引：0
|
作者：
El Mansari, M. [1 ]
Lecours, M. [1 ]
Biler, P. [1 ]
机构：
[1] Mental Hlth Res Inst, Ottawa, ON, Canada
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-14-011
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [21] Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters-A rat microdialysis and electrophysiology study
    Pehrson, Alan L.
    Cremers, Thomas
    Betry, Cecile
    van der Hart, Marieke G. C.
    Jorgensen, Laerke
    Madsen, Mathias
    Haddjeri, Nasser
    Ebert, Bjarke
    Sanchez, Connie
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (02) : 133 - 145
  • [22] Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
    Mork, A.
    Pehrson, A.
    Brennum, L. T.
    Nielsen, S. Moller
    Zhong, H.
    Lassen, A. B.
    Miller, S.
    Westrich, L.
    Boyle, N. J.
    Sanchez, C.
    Fischer, C. W.
    Liebenberg, N.
    Wegener, G.
    Bundgaard, C.
    Hogg, S.
    Bang-Andersen, B.
    Stensbol, T. Bryan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (03): : 666 - 675
  • [23] 5HT1A AGONIST ACTIVITY AND THE ANTIDEPRESSANT EFFICACY OF LU AA21004
    Mayze, T.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [24] Vortioxetine (Lu Aa21004), An Investigational Multimodal Antidepressant: Differentiation from Currently Used Antidepressants in Preclinical Rodent Models
    Sanchez, Connie
    Pehrson, Alan L.
    Betry, Cecille
    David, Denis
    Li, Yan
    Gulinello, Maria
    Leiser, Steve C.
    Haddjeri, Nasser
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 106S - 107S
  • [25] RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS OF LU AA21004
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1114 - 1114
  • [26] The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder
    Florea, I.
    Dragheim, M.
    Loft, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S255 - S256
  • [27] Lu AA21004: a novel potential treatment for mood disorders
    Moore, N.
    Bang-Andersen, B.
    Brennum, L.
    Fredriksen, K.
    Hogg, S.
    Mork, A.
    Stensbol, T.
    Zhong, H.
    Sanchez, C.
    Smith, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S321 - S321
  • [28] EFFECT OF FOOD ON THE PHARMACOKINETICS OF LU AA21004 IN HEALTHY VOLUNTEERS
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1115 - 1115
  • [29] THE ABSOLUTE BIOAVAILABILITY AND CLINICAL PHARMACOKINETICS AFTER INTRAVENOUS AND ORAL ADMINISTRATION OF THE NOVEL ANTIDEPRESSANT LU AA21004
    Hojer, A. -M
    Areberg, J.
    Sogaard, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 150 - 150
  • [30] Lu AA21004, a novel antidepressant, modulates neurotransmitter levels and theta oscillations, and exerts pro-cognitive effects in rats
    Arbell, M.
    Diaz, M. C.
    Morales, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S407 - S408
12345